These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23065261)

  • 1. Prognostic impact of Metadherin-SND1 interaction in colon cancer.
    Wang N; Du X; Zang L; Song N; Yang T; Dong R; Wu T; He X; Lu J
    Mol Biol Rep; 2012 Dec; 39(12):10497-504. PubMed ID: 23065261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into the tumor-promoting function of the MTDH-SND1 complex.
    Guo F; Wan L; Zheng A; Stanevich V; Wei Y; Satyshur KA; Shen M; Lee W; Kang Y; Xing Y
    Cell Rep; 2014 Sep; 8(6):1704-1713. PubMed ID: 25242325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
    Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
    Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.
    Blanco MA; Alečković M; Hua Y; Li T; Wei Y; Xu Z; Cristea IM; Kang Y
    J Biol Chem; 2011 Jun; 286(22):19982-92. PubMed ID: 21478147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlated overexpression of metadherin and SND1 in glioma cells.
    Tong L; Wang C; Hu X; Pang B; Yang Z; He Z; He M; Wei L; Chu M
    Biol Chem; 2016 Jan; 397(1):57-65. PubMed ID: 26351803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
    He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Small Inhibitors for Human Metadherin, an Oncoprotein, through
    Khattak AA; Ahmad A; Khattak HA; Irshad Khan MZ
    Curr Comput Aided Drug Des; 2023; 19(4):278-287. PubMed ID: 36627784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells
    Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
    Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction.
    Chen H; Zhan M; Liu J; Liu Z; Shen M; Yang F; Kang Y; Yin F; Li Z
    J Med Chem; 2022 Sep; 65(18):12188-12199. PubMed ID: 36044768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.
    Shen M; Wei Y; Kim H; Wan L; Jiang YZ; Hang X; Raba M; Remiszewski S; Rowicki M; Wu CG; Wu S; Zhang L; Lu X; Yuan M; Smith HA; Zheng A; Bertino J; Jin JF; Xing Y; Shao ZM; Kang Y
    Nat Cancer; 2022 Jan; 3(1):43-59. PubMed ID: 35121987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
    Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
    Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
    Wang X; Cai L; Ye F; Li M; Ma L; Geng C; Song Z; Liu Y
    Medicine (Baltimore); 2019 Sep; 98(36):e16937. PubMed ID: 31490377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.
    Abdel Ghafar MT; Soliman NA
    Adv Clin Chem; 2022; 106():235-280. PubMed ID: 35152973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of metadherin in estrogen-regulated gene expression.
    Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
    Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
    Li WF; Wang G; Zhao ZB; Liu CA
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
    Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
    Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
    Liu DC; Yang ZL
    Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.
    Tokunaga E; Nakashima Y; Yamashita N; Hisamatsu Y; Okada S; Akiyoshi S; Aishima S; Kitao H; Morita M; Maehara Y
    Breast Cancer; 2014 May; 21(3):341-9. PubMed ID: 22903204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue.
    Su P; Zhang Q; Yang Q
    Diagn Pathol; 2010 Jun; 5():38. PubMed ID: 20565850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SND1 expression in breast cancer tumors is associated with poor prognosis.
    Gu X; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
    Ann N Y Acad Sci; 2018 Dec; 1433(1):53-60. PubMed ID: 30216461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.